Caregen Co.Ltd vs Prestige Biologics Co.: Fair Value & Quality
Both stocks run through our valuation models. Here is how Caregen Co.Ltd (214370) and Prestige Biologics Co. (334970) compare, as of Oct 4, 2026.
Head-to-head numbers
Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.
betterweakerfor reference, not scored
Prestige Biologics Co. leads: 2 to 3 metric wins.
n/a = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
What the models say
How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.
▲above the price, more than 15% above ●close to the price, 85% to 115% of the price ▼below the price, more than 15% below
| Model family | Caregen Co.LtdPrice KRW 42,550 | Prestige Biologics Co.Price KRW 1,434 |
|---|---|---|
| DCF Models | ▼−87.9%below the priceKRW 5,151 | n/a |
| Earnings-Based | ▼−94.3%below the priceKRW 2,414 | n/a |
| Dividend Discount | ▼−82.3%below the priceKRW 7,530 | n/a |
| Multiples | ▼−83.2%below the priceKRW 7,134 | n/a |
| Asset-Based | ▼−93.2%below the priceKRW 2,913 | ▼−34.5%below the priceKRW 939 |
| Growth DCF | ▼−90.7%below the priceKRW 3,963 | n/a |
| Economic Profit | ▼−92.6%below the priceKRW 3,143 | n/a |
| Growth Earnings | ▼−82.6%below the priceKRW 7,396 | n/a |
| Minimum | ▼−94.3%below the priceKRW 2,414 | ▼−34.5%below the priceKRW 939 |
| Maximum | ▼−82.3%below the priceKRW 7,530 | ▼−34.5%below the priceKRW 939 |
| Median | ▼−89.3%below the priceKRW 4,557 | ▼−34.5%below the priceKRW 939 |
| Geometric mean | ▼−89.3%below the priceKRW 4,536 | ▼−34.5%below the priceKRW 939 |
Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.
Caregen Co.Ltd: 25 of 25 models see the stock below the current price.
Prestige Biologics Co.: 1 of 1 models see the stock below the current price.
Scenario ranges
From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Caregen Co.Ltd · Health Care
Prestige Biologics Co. · Health Care
Bottom line
As of Oct 4, 2026, Fair Value Calculator sees Prestige Biologics Co. as the less overvalued of the two: Caregen Co.Ltd trades at KRW 42,550 versus a fair value of KRW 5,414 (−87.3%), while Prestige Biologics Co. trades at KRW 1,434 versus KRW 983 (−31.5%).
Caregen Co.Ltd has the higher quality score (71/100).
Open Prestige Biologics Co. live analysis →More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Related to Caregen Co.Ltd
Eli Lilly and vs UnitedHealth GroupAmgen vs Eli Lilly andGilead Sciences vs Eli Lilly andJohnson & Johnson vs UnitedHealth GroupRelated to Prestige Biologics Co.
Amgen vs Johnson & JohnsonGilead Sciences vs Johnson & JohnsonAbbVie vs UnitedHealth GroupAlphabet Inc Class C vs NetflixSee the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.